TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Elevation Oncology ( (ELEV) ) is now available.
On March 31, 2025, Elevation Oncology announced that Chief Medical Officer Dr. Valerie M. Jansen stepped down from her position. Dr. Jansen will receive severance benefits as per her agreement with the company, including a lump-sum payment, healthcare coverage, and accelerated vesting of equity awards. This transition is part of a separation agreement that includes standard legal provisions, potentially impacting the company’s operational dynamics and stakeholder relations.
More about Elevation Oncology
Elevation Oncology, Inc. operates in the biotechnology industry, focusing on the development of precision medicines for the treatment of cancer.
YTD Price Performance: -56.83%
Average Trading Volume: 2,627,012
Technical Sentiment Signal: Buy
Current Market Cap: $15.34M
See more data about ELEV stock on TipRanks’ Stock Analysis page.